Stock Market ke Experts ki Raay
Analysts ne Wednesday ke liye pharmaceutical, power, automobile, aur consumer segments se stocks choose kiye hain. Adlytick.in ke Founder Aditya Arora, Invest4edu Research And Investments ke Head Aditya Agarwala, aur Reliance Securities Research ke Head Vikas Jain ne stocks par apni raay di. Chaliye dekhte hain unhone kya kaha.
Gillette India
Adlytick.in ke Aditya Arora ne Gillette India Ltd. ko buy karne ki salaah di hai. Target price Rs 10,172 apiece hai, jo Tuesday ke closing price se 5.8% upar hai. Stop loss Rs 9,600 apiece par hai. Bloomberg data ke anusaar, company ko track karne wale do analysts ne ‘buy’ rating maintain ki hai. Average 12-month consensus price target 1.1% upside imply karta hai.
Eris Lifesciences
Arora ne is stock ko bhi buy karne ki salaah di. Target price Rs 1,752 apiece hai, jo Tuesday ke closing price se 4.1% upar hai. Stop loss Rs 1,632 apiece par hai. Bloomberg data ke anusaar, company ko track karne wale 11 analysts mein se 10 ne ‘buy’ rating maintain ki hai, aur ek ne ‘hold’ recommend kiya hai. Average 12-month consensus price target 2.7% downside imply karta hai.
Tata Motors
Invest4edu ke Aditya Agarwala ne Tata Motors ko buy karne ki salaah di hai. Target price Rs 785 apiece hai, jo Tuesday ke closing price se 7.1% upar hai. Stop loss Rs 700 apiece par hai. Bloomberg data ke anusaar, company ko track karne wale 35 analysts mein se 18 ne ‘buy’ rating maintain ki hai, 11 ne ‘hold’ recommend kiya hai aur 6 ne ‘sell’ suggest kiya hai. Average 12-month consensus price target 3.0% upside imply karta hai.
Power Grid Corp.
Invest4edu se Power Grid Corp. of India ko buy recommendation mila hai. Stock ke liye target price Rs 325 apiece hai, jo Tuesday ke closing price se 8% upar hai. Stop loss Rs 290 apiece par hai. Bloomberg data ke anusaar, company ko track karne wale 24 analysts mein se 16 ne ‘buy’ rating maintain ki hai, 2 ne ‘hold’ recommend kiya hai aur 6 ne ‘sell’ suggest kiya hai. Average 12-month consensus price target 7.0% upside imply karta hai.
Mankind Pharma
Reliance Securities ke Vikas Jain ne Mankind Pharma Ltd. ke liye buy recommendation di. Target price Rs 2,650 tha, jo Tuesday ke closing price se 11% upar hai. Stop loss Rs 2,250 apiece par tha. Bloomberg data ke anusaar, company ko track karne wale 16 analysts mein se 12 ne ‘buy’ rating maintain ki hai, 2 ne ‘hold’ recommend kiya hai, aur 2 ne ‘sell’ suggest kiya hai. Average 12-month consensus price target 14.2% upside imply karta hai.
